ORYZON GENOMICS, S.A. «...678910...» Página 7 de 11 desde 01/07/1988 hasta 13/10/2024 31/03/2017 06:56 ORYZON GENOMICS, S.A. Increases and decreases of share capital. - Block trades The Company informs about the approval by the Board of Directors of a share capital increase, as well as about the procedure by means of which the private placement has been carried out and the results of said placement. Número de registro: 250161 24/02/2017 18:17 ORYZON GENOMICS, S.A. Information on P&L The company sends press release about 2016 Financial Results (Spanish) Número de registro: 248617 24/02/2017 17:52 ORYZON GENOMICS, S.A. Board of directors remuneration annual statement La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del Ejercicio 2016 Número de registro: 248605 24/02/2017 17:50 ORYZON GENOMICS, S.A. Corporate governance annual report La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2016 Número de registro: 248604 24/02/2017 17:48 ORYZON GENOMICS, S.A. Interim financial information La sociedad remite información sobre los resultados del segundo semestre de 2016 Número de registro: 248603 24/02/2017 17:35 ORYZON GENOMICS, S.A. Information on P&L. - Others about corporate governance La Sociedad informa de los principales acuerdos adoptados en la reunión del Consejo de Administración del 23 de febrero de 2017 Número de registro: 248599 18/01/2017 19:07 ORYZON GENOMICS, S.A. Shareholders agreements affecting voting rights Comunication of the termination of the shareholders´ agreement and its addendum entered into by Grupo Ferrer Internacional, S.A., Najeti Capital, S.A.U., Mr. Carlos Buesa Arjol, Oryzon Genomics, S.A., Mr. José María Echarri Torres and Ms. Tamara Maes Número de registro: 247253 Relacionado con 232311 del 14/12/2015 (19:39) 17/01/2017 18:27 ORYZON GENOMICS, S.A. Shareholders agreements affecting voting rights Comunication of the termination of the shareholders´ agreement and its addendum entered into by Corporación Sant Bernat, S.L. (en liquidación), ?Najeti Capital, S.A.U., Mr. Carlos Buesa Arjol, Oryzon Genomics, S.A. and Ms. Tamara Maes. Número de registro: 247217 Relacionado con 232308 del 14/12/2015 (19:31) 03/01/2017 11:31 ORYZON GENOMICS, S.A. Liquidity contracts and specialists The Company submits quarterly reporting of transactions under the liquidity contract Número de registro: 246794 05/12/2016 21:34 ORYZON GENOMICS, S.A. R&D: new licenses, patents and registered trademarks Oryzon announces top-line results from the Phase I/IIA clinical trial with ORY-1001 Número de registro: 245820 Página 7 de 11 «...678910...»